SARS-CoV-2 antibody responses in children with MIS-C and mild and severe COVID-19

This article has 1 evaluations Published on
Read the full article Related papers
This article on Sciety

Abstract

SARS-CoV-2 antibody responses in children remain poorly characterized. Here, we show that pediatric patients with multisystem inflammatory syndrome in children (MIS-C) possess higher SARS-CoV-2 spike IgG titers compared to those with severe coronavirus disease 2019 (COVID-19), likely reflecting a longer time since onset of infection in MIS-C patients.

Related articles

Related articles are currently not available for this article.